Rapid Dose Therapeutics Corp. (CSE:DOSE)
Canada · Delayed Price · Currency is CAD | Market Cap | 16.37M -33.4% |
| Revenue (ttm) | 2.58M +4.3% |
| Net Income | -3.17M |
| EPS | -0.02 |
| Shares Out | 136.44M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 34,500 |
| Open | 0.1050 |
| Previous Close | 0.1100 |
| Day's Range | 0.1000 - 0.1200 |
| 52-Week Range | 0.0800 - 0.1900 |
| Beta | -0.84 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Oct 30, 2026 |
About Rapid Dose Therapeutics
Rapid Dose Therapeutics Corp., a life sciences company, provides drug delivery technologies in Canada. The company offers QuickStrip/PharmaStrip, an oral fast-dissolving drug delivery system designed to rapidly release pharmaceuticals, emulsified oils, and over-the-counter medicines into the bloodstream. It also provides over-the-counter products consisting of QuickStrip Energy to deliver energizing caffeine; QuickStrip B12 to deliver vitamin B12; and QuickStrip Sleep to deliver melatonin, as well as dental products including Lidocaine QuickStr... [Read more]
Financial Performance
In fiscal year 2026, Rapid Dose Therapeutics's revenue was 2.77 million, an increase of 33.00% compared to the previous year's 2.09 million. Losses were -3.39 million, -37.28% less than in 2025.
Financial StatementsNews
Rapid Dose Announces Payment in Shares for Quarterly Interest on Secured Debt
Burlington, Ontario--(Newsfile Corp. - July 10, 2026) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") announced today that pursuant to the terms of its amended and restated secure...
Rapid Dose Completes Extension to Promissory Notes
Burlington, Ontario--(Newsfile Corp. - December 8, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") announced today that it has extended the maturity date of its outstanding ...
Rapid Dose Announces Extension to Promissory Notes
Burlington, Ontario--(Newsfile Corp. - November 28, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") announced today that it intends to extend the maturity date of its outsta...
Rapid Dose Announces Proposed Private Placement Financing
BURLINGTON, Ontario--(BUSINESS WIRE)--Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE) today announced that it plans to complete a private placement financing (the “Financing”) for u...
Rapid Dose Therapeutics Provides Update on Failure to File Cease Trade Order
BURLINGTON, Ontario--(BUSINESS WIRE)--Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotechnology company revolutionizing drug delivery through innovation, announces t...
Rapid Dose Therapeutics to Participate in the Venture Mentoring Services Program in Partnership with Maryland Tech Council and Canada's Trade Commissioner Service
BURLINGTON, Ontario--(BUSINESS WIRE)--Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotechnology company revolutionizing drug delivery through innovation, is one of f...
Rapid Dose Therapeutics Enters Supplier and Purchase Agreement with a Leading Gas and Convenience Store Retailer for Nutraceutical and Vitamin Products
BURLINGTON, Ontario--(BUSINESS WIRE)--Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotechnology company focused on health and wellness leveraging an innovative, prop...
Rapid Dose Therapeutics Confirms Delay in Filing Annual Financial Statements and Issuance of Failure-to-File Cease Trade Order
BURLINGTON, Ontario--(BUSINESS WIRE)--Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotechnology company revolutionizing drug delivery through innovation, confirms th...
Rapid Dose Therapeutics Provides Bi-Weekly MCTO Status Update
BURLINGTON, Ontario--(BUSINESS WIRE)--Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotechnology company revolutionizing drug delivery through innovation, is providin...
Rapid Dose Therapeutics Announces Closing of First Tranche of Private Placement
BURLINGTON, Ontario--(BUSINESS WIRE)--Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotechnology company revolutionizing drug delivery through innovation, today annou...
Rapid Dose Therapeutics Announces Issuance of Management Cease Trade Order
BURLINGTON, Ontario--(BUSINESS WIRE)--Rapid Dose Therapeutics Corp. (“RDT”), (CSE: DOSE), a Canadian biotechnology company leveraging an innovative, proprietary oral delivery platform, announces that,...
Rapid Dose Therapeutics Announces Delay in Filing Annual Financial Statements
BURLINGTON, Ontario--(BUSINESS WIRE)--Rapid Dose Therapeutics Announces Delay in Filing Annual Financial Statements
Rapid Dose Therapeutics Corp Announces Proposed Private Placement
BURLINGTON, Ontario--(BUSINESS WIRE)--Rapid Dose Therapeutics Corp Announces Proposed Private Placement
Rapid Dose Therapeutics Closes First Tranche of Private Placement
BURLINGTON, Ontario--(BUSINESS WIRE)--Rapid Dose Therapeutics Closes First Tranche of Private Placement
Rapid Dose Therapeutics Provides Shareholder Update Regarding Vaccine Collaboration Agreement with Oakland Health Limited in the United Kingdom
BURLINGTON, Ontario--(BUSINESS WIRE)--Rapid Dose Therapeutics Corp. (“RDT”), (CSE: DOSE), a Canadian biotechnology company leveraging an innovative, proprietary oral delivery platform, provides the fo...
Rapid Dose Therapeutics and Skycare Compounding Labs to Provide Patients with a Novel Oral Delivery Option for Pharmaceutical Products
BURLINGTON, Ontario--(BUSINESS WIRE)--Rapid Dose Therapeutics and Skycare Compounding Labs to Provide Patients with a Novel Oral Delivery Option for Pharmaceutical Products
RD Therapeutics and Rapid Dose Therapeutics Participate in the CEPI Global Pandemic Preparedness Summit and Support the #100DaysMission
BURLINGTON, Ontario--(BUSINESS WIRE)-- #100DaysMission--Value of needle-free vaccination to be discussed at the CEPI Global Pandemic Preparedness Summit, supporting the #100DaysMission
Rapid Dose Therapeutics Announces Management Change
BURLINGTON, Ontario--(BUSINESS WIRE)--Rapid Dose Therapeutics announces management change
Rapid Dose Therapeutics Appoints Dr. Michael Glogauer to Advisory Board
BURLINGTON, Ontario--(BUSINESS WIRE)--Rapid Dose Therapeutics Appoints Dr. Michael Glogauer to Advisory Board
Rapid Dose Therapeutics and McMaster University's COVID-19 Vaccine Study Receives NSERC Research and Development Grant
BURLINGTON, Ontario--(BUSINESS WIRE)---- $DOSE--Today, Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE) and McMaster University (“McMaster”) are pleased to announce that the ongoing ...